Blog

Aparna Kesarwala has been named a 2024 Gilead Research Scholar – Winship Cancer Institute of Emory University

Photo taken from Winship Cancer Institute of Emory University/X

Jun 13, 2024, 09:39

Aparna Kesarwala has been named a 2024 Gilead Research Scholar – Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University announced on X: .

“Winship researcher Aparna Kesarwala, MD, PhD, has been named a 2024 Gilead Research Scholar. The two-year, $180,000 award will support her project, ‘Combination targeting of metabolic transporters with radiation therapy in lung cancer.’ Learn more.”

Source: Winship Cancer Institute of Emory University/X

Aparna Kesarwala cancer cancer research funding cancer treatment advancements Emory University Emory University researchers Gilead Research Scholar lung cancer research metabolic transporters OncoDaily Oncology oncology research radiation therapy Winship Cancer Institute

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology